The unlimited availability of biosynthetic human growth hormone (rhGH) has contributed to the disassociation of the treatment of short stature from its causes. The rationale for treatment has traditionally rested upon the assumption that short stature, in the extreme, may constitute a physical disability, and otherwise represents a significant psychosocial burden for the individual. This review summarizes what is known about the psychosocial aspects of short stature and the quality of life benefits of rhGH treatment. Stereotypes and assumptions about short stature are evaluated in light of empirical findings. Problems of psychosocial adjustment are relatively common in the general population. Because of the salience of short stature, and its potential to serve as a lightning rod to divert attention from other factors interfering with a healthy psychological adaptation, the clinician must be watchful of misattributions for ongoing problems, or unrealistic predictions of the benefits of taller stature. For these reasons, the clinician should consider incorporating a psychosocial component in the diagnostic evaluation to broaden potential treatment recommendations. Finally, studies of factors influencing family decisions regarding factors for and against rhGH therapy provide important clues to how clinicians might enhance the informed consent process.

Keywords:
Short stature, Stigmatization, psychosocial adaptation, Juvenilization, rhGH therapy, informed consent, Growth hormone treatment of short stature, Stature-related stereotypes, QoL assumptions regarding short stature
1.
Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, et al: Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001;86:3061–3069.
2.
Vimalachandra D, Craig JC, Cowell CT, Knight JF: Growth hormone treatment in children with chronic renal failure: A meta-analysis of randomized controlled trials. J Pediatr 2001;139:560–567.
3.
Cassidy SB: Prader-Willi syndrome in the new millennium. Endocrinologist 2001;10(suppl 1):1S–73S.
4.
Sas T, de Waal W, Mulder P, Houdijk M, Jansen M, Reeser M, et al: Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. J Clin Endocrinol Metab 1999;84:3064–3070.
5.
Finkelstein BS, Imperiale TF, Speroff T, Marrero U, Radcliffe DJ, Cuttler L: Effect of growth hormone therapy on height in children with idiopathic short stature: A meta-analysis. Arch Pediatr Adolesc Med 2002;156:230–240.
6.
Allen DB, Fost N: hGH for short stature: Ethical issues raised by expanded access. J Pediatr 2004;144:648–652.
7.
US Food and Drug Administration: FDA approves Humatrope for short stature. FDA Talk Paper. July 25, 2003. Available at: www.fda.gov/bbs/topics/ANSWERS/2003/ANS01242.html. Accessed May 3, 2005.
8.
Clopper R, Mazur T, Ellis AM, Michael P: Height and children’s stereotypes; in Stabler B, Underwood LE (eds): Growth, Stature, and Adaptation. Chapel Hill, University of North Carolina at Chapel Hill, 1994, pp 7–18.
9.
Martel LF, Biller H: Stature and Stigma: The Biopsychosocial Development of Short Males. Lexington, Lexington Books, 1987.
10.
Jackson LA, Ervin KS: Height stereotypes of women and men: The liabilities of shortness for both sexes. J Soc Psychol 1992;132:433–445.
11.
Gacsaly SA, Borges CA: The male physique and behavioral expectancies. J Psychol 1979;101:97–102.
12.
Voss LD, Mulligan J: Bullying in school: Are short pupils at risk? Questionnaire study in a cohort. BMJ 2000;320:612–613.
13.
Arkoff A, Weaver HB: Body image and body dissatisfaction in Japanese-Americans. J Soc Psychol1966;68:323–330.
14.
Rekers-Mombarg LT, Busschbach JJ, Massa GG, Dicke J, Wit JM: Quality of life of young adults with idiopathic short stature: Effect of growth hormone treatment. Acta Paediatr 1998;87:865–870.
15.
Underwood LE: The social cost of being short: Societal perceptions and biases. Acta Paediatr Suppl 1991;377:3–8.
16.
Eisenberg N, Roth K, Bryniarski KA, Murray E: Sex differences in the relationship of height to children’s actual and attributed social and cognitive competencies. Sex Roles 1984;11:719–734.
17.
Hartnett JJ, Bailey KG, Hartley CS: Body height, position, and sex as determinants of personal space. J Psychol 1974;87:129–136.
18.
Bailey KG, Caffrey JV, Hartnett JJ: Body size as implied threat: Effects on personal space and person perception. Percept Mot Skills 1976;43:223–230.
19.
Beigel HG: Body height in mate selection. J Soc Psychol 1954;39:257–268.
20.
Graziano W, Brothen T, Berscheid E: Height and attraction: Do men and women see eye-to-eye? J Pers 1978;46:128–145.
21.
Hensley WE: Height as a basis for interpersonal attraction. Adolescence 1994;29:469–474.
22.
Pierce CA: Body height and romantic attraction: A meta-analytic test of the male-taller norm. Soc Behav Pers 1996;24:143–150.
23.
Brackbill Y, Nevill DD: Parental expectations of achievement as affected by children’s height. Merrill-Palmer Q 1981;27:429–441.
24.
Wilson PR: Perceptual distortion of height as a function of ascribed academic status. J Soc Psychol 1968;74:97–102.
25.
Lechelt EC: Occupational affiliation and ratings of physical height and personal esteem. Psychol Rep 1975;36:943–946.
26.
Sandberg DE: Short stature: Intellectual and behavioral aspects; in Lifshitz F (ed): Pediatric Endocrinology, ed 3. New York, Dekker, 1996, pp 149–162.
27.
Sandberg DE, Michael P: Psychosocial stresses related to short stature: Does their presence imply psychiatric dysfunction? In Drotar D (ed): Assessing Pediatric Health-Related Quality of Life and Functional Status: Implications for Research. Mahwah, Lawrence Erlbaum Assoc, 1998, pp 287–312.
28.
Zimet GD, Cutler M, Litvene M, Dahms W, Owens R, Cuttler L: Psychological adjustment of children evaluated for short stature: a preliminary report. J Dev Behav Pediatr 1995;16:264–270.
29.
Meyer-Bahlburg HFL: Short stature: Psychological issues; in Lifshitz F (ed): Pediatric Endocrinology. New York, Dekker, 1990, pp 173–196.
30.
Gould MS, Wunsch-Hitzig R, Dohrenwend B: Estimating the prevalence of childhood psychopathology. A critical review. J Am Acad Child Psychiatry 1981;20:462–476.
31.
Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME, et al: The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry 1996;35:865–877.
32.
Theunissen NC, Kamp GA, Koopman HM, Zwinderman KA, Vogels T, Wit JM: Quality of life and self-esteem in children treated for idiopathic short stature. J Pediatr 2002;140:507–515.
33.
Sandberg DE, Brook AE, Campos SP: Short stature: a psychosocial burden requiring growth hormone therapy? Pediatrics 1994;94:832–840.
34.
Stabler B, Clopper RR, Siegel PT, Stoppani C, Compton PG, Underwood LE: Academic achievement and psychological adjustment in short children. The National Cooperative Growth Study. J Dev Behav Pediatr 1994;15:1–6.
35.
Steinhausen HC, Dorr HG, Kannenberg R, Malin Z: The behavior profile of children and adolescents with short stature. J Dev Behav Pediatr 2000;21:423–428.
36.
Sandberg DE, Kranzler J, Bukowski WM, Rosenbloom AL: Psychosocial aspects of short stature and growth hormone therapy. J Pediatr 1999;135:133–134.
37.
Gilmour J, Skuse D: Short stature – the role of intelligence in psychosocial adjustment. Arch Dis Child 1996;75:25–31.
38.
Voss LD, Mulligan J: The short ‘normal’ child in school: Self-esteem, behavior and attainment before puberty (The Wessex Growth Study); in Stabler B, Underwood LE (eds): Growth, Stature and Adaptation. Chapel Hill, University of North Carolina at Chapel Hill Press, 1994, pp 47–64.
39.
Downie AB, Mulligan J, Stratford RJ, Betts PR, Voss LD: Are short normal children at a disadvantage? The Wessex Growth Study. BMJ 1997;314:97–100.
40.
Voss LD: Short but normal. Arch Dis Child 1999;81:370–371.
41.
Ulph F, Betts P, Mulligan J, Stratford RJ: Personality functioning: the influence of stature. Arch Dis Child 2004;89:17–21.
42.
Wilson DM, Hammer LD, Duncan PM, Dornbusch SM, Ritter PL, Hintz RL, et al: Growth and intellectual development. Pediatrics 1986;78:646–650.
43.
Sandberg DE, Bukowski WM, Fung CM, Noll RB: Height and social adjustment: Are extremes a cause for concern and action? Pediatrics 2004;114:744–750.
44.
Ekwo E, Gosselink C, Roizen N, Brazdziunas D: The effect of height on family income. Am J Hum Biol 1991;3:181–188.
45.
Harper B: Beauty, stature and the labour market: A British cohort study. Oxford Bull Econ Statist 2000;62:771–800.
46.
Sargent JD, Blanchflower DG: Obesity and stature in adolescence and earnings in young adulthood. Analysis of a British birth cohort. Arch Pediatr Adolesc Med 1994;148:681–687.
47.
Persico N, Postlewaite RJ, Silverman D: The effect of adolescent experience on labor market outcomes: The case of height. J Polit Econ 2004;112:1019–1053.
48.
Judge TA, Cable DM: The effect of physical height on workplace success and income: Preliminary test of a theoretical model. J Appl Psychol 2004;89:428–441.
49.
Fu H, Goldman N: Incorporating health into models of marriage choice: Demographic and sociological perspectives. J Marriage Fam 1996;58:740–758.
50.
Fu H, Goldman N: The association between health-related behaviours and the risk of divorce in the USA. J Biosoc Sci 2000;32:63–88.
51.
Keltner D, Capps L, Kring AM, Young RC, Heerey EA: Just teasing: A conceptual analysis and empirical review. Psychol Bull 2001;127:229–248.
52.
Warm TR: The role of teasing in development and vice versa. J Dev Behav Pediatr 1997;18:97–101.
53.
Downie AB, Mulligan J, McCaughey ES, Stratford RJ, Betts PR, Voss LD: Psychological response to growth hormone treatment in short normal children. Arch Dis Child 1996;75:32–35.
54.
Ross JL, Sandberg DE, Rose SR, Leschek EW, Baron J, Chipman JJ, et al: Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. J Clin Endocrinol Metab 2004;89:4873–4878.
55.
Wilson DM, McCauley E, Brown DR, Dudley R: Oxandrolone therapy in constitutionally delayed growth and puberty. Bio-Technology General Corporation Cooperative Study Group. Pediatrics 1995;96:1095–1100.
56.
Strickland AL: Long-term results of treatment with low-dose fluoxymesterone in constitutional delay of growth and puberty and in genetic short stature. Pediatrics 1993;91:716–720.
57.
Richman RA, Kirsch LR: Testosterone treatment in adolescent boys with constitutional delay in growth and development. N Engl J Med 1988;319:1563–1567.
58.
Anonymous: Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995;127:857–867.
59.
Noeker M, Haverkamp F: Adjustment in conditions with short stature: A conceptual framework. J Pediatr Endocrinol Metab 2000;13:1585–1594.
60.
Finkelstein BS, Singh J, Silvers JB, Marrero U, Neuhauser D, Cuttler L: Patient attitudes and preferences regarding treatment: GH therapy for childhood short stature. Horm Res 1999;51(suppl 1):67–72.
61.
Singh J, Cuttler L, Shin M, Silvers JB, Neuhauser D: Medical decision-making and the patient: understanding preference patterns for growth hormone therapy using conjoint analysis. Medical Care 1998;36(suppl 8):AS31–AS45.
62.
Kazdin AE: Research Design in Clinical Psychology, ed 4. Boston, Allyn & Bacon, 2003.
63.
Eminson DM, Powell RP, Hollis S: Cognitive behavioral interventions with short statured boys: a pilot study; in Stabler B, Underwood LE (eds): Growth, Stature, and Adaptation. Chapel Hill, The University of North Carolina at Chapel Hill, 1994, pp 135–150.
64.
Grimberg A, Kutikov JK, Cucchiara AJ: Sex differences in patients referred for evaluation of poor growth. J Pediatr 2005;146:212–216.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.